BD GENERICS ApS: Financial statements 2022
CVR: 28707207
Source: annual report 2022, Danish Business Authority
01/07/2021 – 30/06/2022
BD GENERICS ApS (CVR 28707207) has filed annual accounts for 2022. In 2022, the company reported a gross profit of DKK -70,263 and a net result of DKK -43,869 compared with DKK -13,336 the year before. Equity in the 2022 report amounted to DKK 828,249. The solvency ratio was 90.9%.
- Revenue
- DKK 0
- Gross Profit
- DKK -70,263
- Profit/Loss
- DKK -43,869
- Equity
- DKK 828,249
- Total Assets
- DKK 911,171
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2022 | 0 | -70 t. | -44 t. | 828 t. | - |
| 2021 | 0 | -7 t. | -13 t. | 872 t. | - |
| 2020 | - | -9 t. | -14 t. | 885 t. | - |
| 2019 | - | -7 t. | -10 t. | 899 t. | - |
| 2018 | - | -44 t. | -48 t. | 910 t. | - |
Keep an eye on BD GENERICS ApS
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringAbout BD GENERICS ApS
BD GENERICS ApS is a Danish company of the type Anpartsselskab based in Brøndby, founded in 2005. The company is registered under the industry Virksomhedsrådgivning og anden ledelsesrådgivning. The management consists of Thomas Gerner Jacobsen. The company is owned by TGJ HOLDING ApS. The company has 1 employee (2009). In 2025, the company reported a gross profit of DKK -117,586 and a net result of DKK -64,678 compared with DKK -61,196 the year before. Equity in the 2025 report amounted to DKK 638,280.